AbbVie Inc. (NYSE:ABBV) Holdings Decreased by Tower Bridge Advisors
Tower Bridge Advisors cut its position in shares of AbbVie Inc. (NYSE:ABBV – Get Rating) by 0.5% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 56,379 shares of the company’s stock after selling 300 shares during the quarter. Tower Bridge Advisors’ holdings in […]